Tenaya Gene Therapy Shows Strong Arrhythmia Reduction in ARVC Trial
SOUTH SAN FRANCISCO, Calif., May 15, 2026 Tenaya Therapeutics reported encouraging interim Phase 1b/2 clinical data for TN-401, its...
ASGCT 2026
Advertisement
MiNK Advances iNKT Cell Therapy Into Phase 2 Validation
NEW YORK, May 15, 2026 MiNK Therapeutics, Inc. reported first quarter 2026 financial results while highlighting major clinical and...
AviadoBio Advances AVB-406 Gene Therapy for Alzheimer’s
LONDON, May 14, 2026 AviadoBio presented new preclinical data at the American Society of Gene and Cell Therapy (ASGCT)...
Mirai Bio Expands LNP Delivery Into Adipocyte Tissue
CAMBRIDGE, Mass., May 14, 2026 Mirai Bio presented new preclinical data at the American Society of Gene and Cell...
GEMMABio Expands Gene Therapy Pipeline for Rare Diseases
PHILADELPHIA, May 14, 2026 GEMMA Biotherapeutics (GEMMABio) unveiled its new Duchenne muscular dystrophy (DMD) gene therapy program and presented...
Advertisements
Encoded Therapeutics Reports Strong ETX101 Results
SOUTH SAN FRANCISCO, Calif. – May 13, 2026 Encoded Therapeutics presented expanded clinical data from its ongoing POLARIS Phase...
Sana Biotechnology Advances In Vivo CAR T Platform
SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...
Neurogene Highlights Rett Gene Therapy Progress at ASGCT
NEW YORK, May 12, 2026 Neurogene presented new data at the 2026 American Society of Gene and Cell Therapy...
Encoded Therapeutics Expands CNS Gene Therapy Pipeline
SOUTH SAN FRANCISCO, Calif., May 12, 2026 Encoded Therapeutics announced new preclinical findings at the 2026 American Society of...
AIRNA Showcases RNA Editing Advances at ASGCT 2026
CAMBRIDGE, Mass., May 12, 2026 AIRNA announced new preclinical findings at the 2026 American Society of Gene and Cell...
Advertisement
